This study aims to better understand people who have advanced or metastatic non-small cell lung cancer (NSCLC) with an EGFR mutation. NSCLC is an advanced stage cancer of the lung, occurring due to mutations (changes) in the EGFR gene. The study will assess the participant demographic background (that is age, gender etc.), the treatments they receive, how well those treatments work, and their health outcomes.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Sociodemographic Characteristics: Age
Timeframe: Baseline
Sociodemographic Characteristics: Sex
Timeframe: Baseline
Sociodemographic Characteristics: Weight
Timeframe: Baseline
Sociodemographic Characteristics: Smoking Status
Timeframe: Baseline
Sociodemographic Characteristics: Eastern Cooperative Oncology Group (ECOG) Performance Status
Timeframe: Baseline
Sociodemographic Characteristics: Disease Histopathology
Timeframe: Baseline
Sociodemographic Characteristics: Type of Mutation
Timeframe: Baseline
Sociodemographic Characteristics: Disease Stage
Timeframe: Baseline
Sociodemographic Characteristics: Cancer Metastasis
Timeframe: Baseline
EGFR Mutation Prevalence
Timeframe: Up to approximately 7 years 9 months
Percentage of Participants by Type of Mutation of EGFR
Timeframe: Up to approximately 7 years 9 months